GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $139,443,000 | +5.0% | 3,203,402 | +5.1% | 0.02% | +23.1% |
| Q1 2022 | $132,823,000 | -3.4% | 3,049,194 | -2.2% | 0.01% | 0.0% |
| Q4 2021 | $137,459,000 | -0.5% | 3,116,993 | -13.8% | 0.01% | -7.1% |
| Q3 2021 | $138,089,000 | +7.7% | 3,613,973 | +12.2% | 0.01% | +7.7% |
| Q2 2021 | $128,260,000 | +14.7% | 3,220,980 | +2.8% | 0.01% | 0.0% |
| Q1 2021 | $111,823,000 | -10.7% | 3,133,164 | -7.9% | 0.01% | -18.8% |
| Q4 2020 | $125,249,000 | -41.3% | 3,403,502 | -40.0% | 0.02% | -44.8% |
| Q3 2020 | $213,407,000 | -16.7% | 5,669,698 | -9.7% | 0.03% | -25.6% |
| Q2 2020 | $256,228,000 | -1.2% | 6,281,607 | -8.3% | 0.04% | -17.0% |
| Q1 2020 | $259,421,000 | -25.9% | 6,846,663 | -8.1% | 0.05% | -6.0% |
| Q4 2019 | $350,080,000 | +12.5% | 7,450,131 | +2.1% | 0.05% | +8.7% |
| Q3 2019 | $311,314,000 | -0.2% | 7,294,143 | -6.5% | 0.05% | -2.1% |
| Q2 2019 | $312,066,000 | -7.7% | 7,797,761 | -3.6% | 0.05% | -11.3% |
| Q1 2019 | $338,166,000 | +16.0% | 8,092,032 | +6.0% | 0.05% | +3.9% |
| Q4 2018 | $291,570,000 | -12.2% | 7,630,744 | -7.7% | 0.05% | -1.9% |
| Q3 2018 | $332,062,000 | +7.0% | 8,266,396 | +7.4% | 0.05% | +2.0% |
| Q2 2018 | $310,394,000 | +2.7% | 7,700,179 | -0.4% | 0.05% | -1.9% |
| Q1 2018 | $302,127,000 | +26.1% | 7,732,954 | +14.5% | 0.05% | +30.0% |
| Q4 2017 | $239,567,000 | -41.7% | 6,754,065 | -33.3% | 0.04% | -38.5% |
| Q3 2017 | $411,262,000 | +25.0% | 10,129,639 | +32.8% | 0.06% | 0.0% |
| Q2 2017 | $329,006,000 | +13.9% | 7,630,001 | +11.4% | 0.06% | +12.1% |
| Q1 2017 | $288,780,000 | +26.8% | 6,849,632 | +15.8% | 0.06% | +18.4% |
| Q4 2016 | $227,775,000 | -20.9% | 5,914,704 | -11.4% | 0.05% | -22.2% |
| Q3 2016 | $287,779,000 | +8.3% | 6,672,369 | +8.8% | 0.06% | +1.6% |
| Q2 2016 | $265,717,000 | +28.1% | 6,130,989 | +19.9% | 0.06% | +24.0% |
| Q1 2016 | $207,415,000 | +16.9% | 5,115,013 | +16.3% | 0.05% | +19.0% |
| Q4 2015 | $177,488,000 | +3.9% | 4,398,700 | -1.0% | 0.04% | 0.0% |
| Q3 2015 | $170,824,000 | +69.6% | 4,442,785 | +83.7% | 0.04% | +27.3% |
| Q2 2015 | $100,750,000 | -22.6% | 2,418,984 | -14.2% | 0.03% | -25.0% |
| Q1 2015 | $130,095,000 | -27.0% | 2,818,957 | -32.4% | 0.04% | -31.2% |
| Q4 2014 | $178,131,000 | -64.5% | 4,167,773 | -61.8% | 0.06% | -60.5% |
| Q3 2014 | $501,997,000 | -12.8% | 10,920,108 | +1.5% | 0.16% | -12.0% |
| Q2 2014 | $575,560,000 | +17.0% | 10,762,151 | +16.9% | 0.18% | +0.5% |
| Q1 2014 | $491,963,000 | +9.0% | 9,207,594 | +8.9% | 0.18% | +13.0% |
| Q4 2013 | $451,217,000 | +171.5% | 8,451,377 | +155.1% | 0.16% | +145.5% |
| Q3 2013 | $166,196,000 | -2.0% | 3,312,679 | -2.3% | 0.07% | -7.0% |
| Q2 2013 | $169,512,000 | – | 3,392,280 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |